179 related articles for article (PubMed ID: 35954254)
1. Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches.
Umar HI; Ajayi AT; Mukerjee N; Aborode AT; Hasan MM; Maitra S; Bello RO; Alabere HO; Sanusi AA; Awolaja OO; Alshehri MM; Chukwuemeka PO; Aljarba NH; Alkahtani S; Malik S; Alexiou A; Ghosh A; Rahman MH
Cells; 2022 Aug; 11(15):. PubMed ID: 35954254
[TBL] [Abstract][Full Text] [Related]
2. Hsp27 as a therapeutic target in cancers.
Acunzo J; Andrieu C; Baylot V; So A; Rocchi P
Curr Drug Targets; 2014 Apr; 15(4):423-31. PubMed ID: 24138636
[TBL] [Abstract][Full Text] [Related]
3. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF.
Konda JD; Olivero M; Musiani D; Lamba S; Di Renzo MF
Mol Oncol; 2017 Jun; 11(6):599-611. PubMed ID: 28182330
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 27 influences the anti-cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation.
Liang HH; Huang CY; Chou CW; Makondi PT; Huang MT; Wei PL; Chang YJ
Life Sci; 2018 Sep; 209():43-51. PubMed ID: 30056019
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
[TBL] [Abstract][Full Text] [Related]
8. The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.
Katsogiannou M; Andrieu C; Baylot V; Baudot A; Dusetti NJ; Gayet O; Finetti P; Garrido C; Birnbaum D; Bertucci F; Brun C; Rocchi P
Mol Cell Proteomics; 2014 Dec; 13(12):3585-601. PubMed ID: 25277244
[TBL] [Abstract][Full Text] [Related]
9. Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets.
McConnell JR; McAlpine SR
Bioorg Med Chem Lett; 2013 Apr; 23(7):1923-8. PubMed ID: 23453837
[TBL] [Abstract][Full Text] [Related]
10. Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Choi SK; Kam H; Kim KY; Park SI; Lee YS
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426426
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.
Hwang SY; Kwak SY; Kwon Y; Lee YS; Na Y
Eur J Med Chem; 2017 Oct; 139():892-900. PubMed ID: 28869891
[TBL] [Abstract][Full Text] [Related]
12. New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells.
Heinrich JC; Donakonda S; Haupt VJ; Lennig P; Zhang Y; Schroeder M
Oncotarget; 2016 Oct; 7(42):68156-68169. PubMed ID: 27626687
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
[TBL] [Abstract][Full Text] [Related]
14. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
Wang X; Chen M; Zhou J; Zhang X
Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
[TBL] [Abstract][Full Text] [Related]
15. An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy.
Olotu F; Adeniji E; Agoni C; Bjij I; Khan S; Elrashedy A; Soliman M
Expert Opin Drug Discov; 2018 Oct; 13(10):903-918. PubMed ID: 30207185
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agents.
Choi SK; Hwang SY; Jeon S; Yoo H; Lee J; Shin JH; Na Y; Kwon Y; Lee YS
Bioorg Chem; 2023 Jan; 130():106260. PubMed ID: 36410114
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors.
Zhong B; Chennamaneni S; Lama R; Yi X; Geldenhuys WJ; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2013 Jul; 56(13):5306-20. PubMed ID: 23767669
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis.
Zhuang H; Jiang W; Cheng W; Qian K; Dong W; Cao L; Huang Q; Li S; Dou F; Chiu JF; Fang XX; Lu M; Hua ZC
Lung Cancer; 2010 Apr; 68(1):27-38. PubMed ID: 19540014
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of heat shock protein 27 confers resistance to actinomycin D-induced apoptosis in cancer cells.
Ma W; Teng Y; Hua H; Hou J; Luo T; Jiang Y
FEBS J; 2013 Sep; 280(18):4612-24. PubMed ID: 23848600
[TBL] [Abstract][Full Text] [Related]
20. In silico evaluation of human small heat shock protein HSP27: homology modeling, mutation analyses and docking studies.
Fossa P; Cichero E
Bioorg Med Chem; 2015 Jul; 23(13):3215-20. PubMed ID: 25999205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
